Talking Genes in Breast and Pancreatic Malignancies

Overview

Journal Mater Sociomed

Date 2019 Aug 28

PMID 31452642

Citations 3

Authors

Mary Barbara

Adrianne Tsen

Laura Tenner

Laura Rosenkranz

Affiliations

Soon will be listed here.

Abstract

Introduction: Both breast and pancreatic cancers have high mortality rates. Breast cancer is while pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death. Almost 4-16 % of individuals with pancreatic cancer have a family history of the disease. Intra-ductal papillary mucinous neoplasms (IPMNs) are cystic lesions that received more attention lately due to their associations with PDAC and other solid organ tumors, such as breast cancer.

Aim: The purpose of this article is to discuss the association of the familiar pancreatic cancer (FPC), sporadic pancreatic cancer, and IPMNs with the breast cancer.

Results: Data is insufficient to prove an association between IPMNs and breast cancer.

Conclusion: The familial clustering of PDAC is not well understood. Further studies are required for greater comprehension of the genetic basis of PDAC and the association between IPMNs and breast cancer.

Citing Articles

Paraganglioma of the Head and Neck: A Review.

Sandow L, Thawani R, Kim M, Heinrich M Endocr Pract. 2022; 29(2):141-147.

PMID: 36252779 PMC: 9979593. DOI: 10.1016/j.eprac.2022.10.002.

Elucidating the molecular signaling pathways of WAVE3.

Kansakar U, Wang W, Markovic V, Sossey-Alaoui K Ann Transl Med. 2020; 8(14):900.

PMID: 32793744 PMC: 7396796. DOI: 10.21037/atm.2020.02.16.

Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.

Gaspersic J, Videtic Paska A Biochem Med (Zagreb). 2020; 30(3):030504.

PMID: 32774122 PMC: 7394254. DOI: 10.11613/BM.2020.030504.

References

. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999; 91(15):1310-6. DOI: 10.1093/jnci/91.15.1310. View

Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod S . Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res. 2000; 60(2):409-16. View

Goggins M, Hruban R, Kern S . BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol. 2000; 156(5):1767-71. PMC: 1876938. DOI: 10.1016/S0002-9440(10)65047-X. View

Murphy K, Brune K, Griffin C, Sollenberger J, Petersen G, Bansal R . Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 2002; 62(13):3789-93. View

Thompson D, Easton D . Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst. 2002; 94(18):1358-65. DOI: 10.1093/jnci/94.18.1358. View

Brose M, Rebbeck T, Calzone K, Stopfer J, Nathanson K, Weber B . Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst. 2002; 94(18):1365-72. DOI: 10.1093/jnci/94.18.1365. View

Hahn S, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B . BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst. 2003; 95(3):214-21. DOI: 10.1093/jnci/95.3.214. View

Thull D, Vogel V . Recognition and management of hereditary breast cancer syndromes. Oncologist. 2004; 9(1):13-24. DOI: 10.1634/theoncologist.9-1-13. View

Klein A, Brune K, Petersen G, Goggins M, Tersmette A, Offerhaus G . Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004; 64(7):2634-8. DOI: 10.1158/0008-5472.can-03-3823. View

10.

Conlon K . Intraductal papillary mucinous tumors of the pancreas. J Clin Oncol. 2005; 23(20):4518-23. DOI: 10.1200/JCO.2005.22.517. View

11.

Couch F, Johnson M, Rabe K, Brune K, de Andrade M, Goggins M . The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(2):342-6. DOI: 10.1158/1055-9965.EPI-06-0783. View

12.

Riall T, Stager V, Nealon W, Townsend Jr C, Kuo Y, Goodwin J . Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. J Am Coll Surg. 2007; 204(5):803-13. DOI: 10.1016/j.jamcollsurg.2007.01.015. View

13.

Brand R, Lerch M, Rubinstein W, Neoptolemos J, Whitcomb D, Hruban R . Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut. 2007; 56(10):1460-9. PMC: 2000231. DOI: 10.1136/gut.2006.108456. View

14.

Tischkowitz M, Sabbaghian N, Ray A, Lange E, Foulkes W, Cooney K . Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. Prostate. 2008; 68(6):675-8. PMC: 2683627. DOI: 10.1002/pros.20729. View

15.

Baumgaertner I, Corcos O, Couvelard A, Sauvanet A, Rebours V, Vullierme M . Prevalence of extrapancreatic cancers in patients with histologically proven intraductal papillary mucinous neoplasms of the pancreas: a case-control study. Am J Gastroenterol. 2008; 103(11):2878-82. DOI: 10.1111/j.1572-0241.2008.02142.x. View

16.

Axilbund J, Argani P, Kamiyama M, Palmisano E, Raben M, Borges M . Absence of germline BRCA1 mutations in familial pancreatic cancer patients. Cancer Biol Ther. 2008; 8(2):131-5. PMC: 2684337. DOI: 10.4161/cbt.8.2.7136. View

17.

Ferrone C, Levine D, Tang L, Allen P, Jarnagin W, Brennan M . BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. J Clin Oncol. 2008; 27(3):433-8. PMC: 3657622. DOI: 10.1200/JCO.2008.18.5546. View

18.

Jones S, Hruban R, Kamiyama M, Borges M, Zhang X, Parsons D . Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science. 2009; 324(5924):217. PMC: 2684332. DOI: 10.1126/science.1171202. View

19.

Raimondi S, Maisonneuve P, Lowenfels A . Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009; 6(12):699-708. DOI: 10.1038/nrgastro.2009.177. View

20.

Reid-Lombardo K, Mathis K, Wood C, Harmsen W, Sarr M . Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management. Ann Surg. 2009; 251(1):64-9. DOI: 10.1097/SLA.0b013e3181b5ad1e. View